Future research agenda—propositions developed through three Delphi rounds
| No | Proposition |
|---|---|
| 1 | More RCTs of both pharmacological and non-pharmacological treatments that give outcomes specific to hip OA are needed |
| 2 | Biological markers for evaluation of the progression of hip OA should be further evaluated |
| 3 | Clinical predictors of response to pharmacological and non-pharmacological interventions for hip OA should be determined |
| 4 | Whether long term use of SYSADOA can retard the progression of hip OA and delay joint replacement should be investigated |
| 5 | RCTs of injection treatments (corticosteroid, hyaluronan) in hip OA are required |
| 6 | The most efficient and effective exercise programme for hip OA should be determined |
| 7 | Studies with appropriate design to determine the comparative effectiveness and cost effectiveness of non-surgical and surgical treatment modalities are needed |
| 8 | Agreed criteria relating to indications and timing of THR are needed |
| 9 | Prospective population based studies are required to improve our knowledge of risk factors for the development and progression of hip OA |
| 10 | Newer imagining techniques (MRI, ultrasound) require validation for the diagnosis and assessment of outcome in trials of hip OA |